Gene expression profile of bioreactor-cultured cardiac cells: activation of morphogenetic pathways for tissue engineering.

Cells grown in three-dimensional (3D) culture take on in vivo phenotypes and organize into tissue-like structures. Understanding the pathways and mechanisms contributing to this in vitro tissuegenesis is a critical goal of tissue engineering. To identify pathways relevant to cardiac tissue engineering, we compared mRNA expression profiles from bioreactor-cultured 3D aggregates of primary neonatal rat heart cells (NRHCs), which form layered structures similar to cardiac tissue, and standard plate-cultured NRHCs, which do not. In a series of two experiments, NRHCs were grown on solid microcarrier surfaces within clinostatically rotated polytetrafluoroethylene (PTFE) vessels and compared to parallel cultures grown on standard tissue culture plates without rotation. After 1, 4, and 6 days, gene expression profiles were analyzed using Affymetrix Rat Genome U34A (RG-U34A) arrays. The results were validated using real-time PCR, and the data set was filtered to generate a list of 93 probe sets that were substantially the same in replicate samples but substantially different between the bioreactor and plate groups. Cluster analysis indicated that the bioreactor and plate samples had similar expression patterns on day 1 but that these patterns diverged thereafter. Database for Annotation, Visualization, and Integrated Discovery (DAVID) analysis revealed a number of statistically significant gene groupings, including groups associated with muscle development and morphogenesis. Further analysis of the annotated gene list indicated that 13 of the 93 filtered genes were associated with endothelial cells, blood vessels, or angiogenesis. These results suggest that 3D aggregate culture of NRHCs in bioreactors is associated with the differential expression of morphogenic and angiogenic pathways similar to those seen during cardiac development.

[1]  A. Bader,et al.  Formation of three‐dimensional fetal myocardial tissue cultures from rat for long‐term cultivation , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[2]  D. Steiner,et al.  Pancreatic beta cells lack a low glucose and O2-inducible mitochondrial protein that augments cell survival. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Kangawa,et al.  Characterization of the PAC1 Variants Expressed in the Mouse Heart , 2006, Annals of the New York Academy of Sciences.

[4]  Michael J Ackerman,et al.  Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. , 2006, Molecular genetics and metabolism.

[5]  M. Bamshad,et al.  Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome , 2006, Nature Genetics.

[6]  M. Fraga,et al.  DNA methyltransferases control telomere length and telomere recombination in mammalian cells , 2006, Nature Cell Biology.

[7]  M. Radisic,et al.  Cardiac tissue engineering: effects of bioreactor flow environment on tissue constructs , 2006 .

[8]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[9]  Thomas Eschenhagen,et al.  Engineering Myocardial Tissue , 2005, Circulation research.

[10]  G. Borschel,et al.  In vivo conditioning of tissue-engineered heart muscle improves contractile performance. , 2005, Artificial organs.

[11]  K. Horiuchi,et al.  Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. , 2005, Developmental biology.

[12]  Pamela R. Fain,et al.  α-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy , 2005 .

[13]  Ravi K Birla,et al.  Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. , 2005, Tissue engineering.

[14]  C. Basson,et al.  Clinical phenotypes and molecular genetic mechanisms of Carney complex. , 2005, The Lancet. Oncology.

[15]  E. Morrisey,et al.  High‐efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α‐Cre transgenic mice , 2005, Genesis.

[16]  G. I. Gallicano,et al.  JAK2/STAT3 Directs Cardiomyogenesis Within Murine Embryonic Stem Cells In Vitro , 2005, Stem cells.

[17]  Ravi Birla,et al.  Self‐organization of rat cardiac cells into contractile 3‐D cardiac tissue , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Peter Carmeliet,et al.  Guidance of vascular and neural network formation , 2005, Current Opinion in Neurobiology.

[19]  J. Coles,et al.  Establishment of vessel-like structures in long-term three-dimensional tissue culture of myocardium: an electron microscopy study. , 2004, Tissue engineering.

[20]  R. Akins,et al.  Exogenous metalloporphyrins alter the organization and function of cultured neonatal rat heart cells via modulation of heme oxygenase activity , 2004, Journal of cellular physiology.

[21]  D. Dube,et al.  Expression of a novel cardiac-specific tropomyosin isoform in humans. , 2004, Biochemical and biophysical research communications.

[22]  Martin Fussenegger,et al.  Design of artificial myocardial microtissues. , 2004, Tissue engineering.

[23]  Thomas Eschenhagen,et al.  Engineered heart tissue for regeneration of diseased hearts. , 2004, Biomaterials.

[24]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[25]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[26]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[27]  V. Cameron,et al.  Minireview: natriuretic peptides during development of the fetal heart and circulation. , 2003, Endocrinology.

[28]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[29]  M. Goumans,et al.  Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells , 2002, Circulation.

[30]  W. Zimmermann,et al.  Tissue Engineering of a Differentiated Cardiac Muscle Construct , 2002, Circulation research.

[31]  W. Stallcup,et al.  NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[32]  M. Bader,et al.  Smooth-muscle contraction without smooth-muscle myosin , 2000, Nature Cell Biology.

[33]  S R Gonda,et al.  Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. , 1999, Tissue engineering.

[34]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Akins,et al.  Neonatal rat heart cells cultured in simulated microgravity , 1997, In Vitro Cellular & Developmental Biology - Animal.

[36]  T. Borg,et al.  Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix , 1994, Journal of cellular physiology.

[37]  N. Sperelakis.  Cultured heart cell reaggregate model for studying cardiac toxicology. , 1978, Environmental health perspectives.